Mean Arterial Pressure and Chronic Kidney Disease Progression in the CKiD Cohort.

Published on Jun 1, 2021in Hypertension7.713
· DOI :10.1161/HYPERTENSIONAHA.120.16692
Janis M. Dionne18
Estimated H-index: 18
(UBC: University of British Columbia),
Shuai Jiang3
Estimated H-index: 3
(Johns Hopkins University)
+ 5 AuthorsJoshua Samuels30
Estimated H-index: 30
(University of Texas Health Science Center at Houston)
Sources
Abstract
Consensus blood pressure guidelines vary in their recommended ambulatory blood pressure targets for children with chronic kidney disease (CKD) because of limited research in this area. We analyzed longitudinal ambulatory blood pressure monitoring data from 679 children with moderate CKD enrolled in the observational CKiD (Chronic Kidney Disease in Children) cohort by time-varying mean arterial pressure (MAP) percentile categories based on the highest wake or sleep MAP percentile. Analyses were stratified by nonglomerular and glomerular diagnoses, with 3 models constructed: unadjusted, adjusted for age, sex, and race, and additional adjustment for proteinuria. The outcome of interest was time to renal replacement therapy or 50% decline in baseline renal function. We found that among children with nonglomerular CKD, MAP percentile was not associated with accelerated disease progression risk until after 4 years of follow-up at which point a high MAP (>90th percentile) was associated with a higher risk of progression to the composite end point (HR, 1.88 [CI, 1.03-3.44]). Among those with glomerular CKD, differential risk for progression began from baseline with the highest risk in those with MAP >90th percentile (HR, 3.23 [CI, 1.34-7.79]). These relationships were attenuated somewhat after adjustment for level of proteinuria, but the trend for higher MAP being associated with higher risk of progression remained significant. Thus, in children with CKD, having ambulatory wake or sleep MAP >90th percentile was associated with higher risk of kidney disease progression with the highest levels of MAP associated with the greatest risk of progression. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00327860.
📖 Papers frequently viewed together
2020
35 Citations
References26
Newest
#1Stephen R. Cole (UNC: University of North Carolina at Chapel Hill)H-Index: 80
#2Jessie K. Edwards (UNC: University of North Carolina at Chapel Hill)H-Index: 19
Last. Alvaro Muñoz (Johns Hopkins University)H-Index: 99
view all 4 authors...
The Kaplan-Meier (KM) estimator of the survival function imputes event times for right-censored and left-truncated observations, but these imputations are hidden and therefore sometimes unrecognized by applied health scientists. Using a simple example data set and the redistribution algorithm, we illustrate how imputations are made by the KM estimator. We also discuss the assumptions necessary for valid analyses of survival data. Illustrating imputations hidden by the KM estimator helps to clari...
1 CitationsSource
#1Ben C ReynoldsH-Index: 7
#2Jennifer Roem (Johns Hopkins University)H-Index: 7
Last. Rulan S. Parekh (Johns Hopkins University)H-Index: 53
view all 8 authors...
Importance Optimal blood pressure (BP) management in children with chronic kidney disease (CKD) slows progression to end-stage renal disease. Studies often base progression risk on a single baseline BP measurement, which may underestimate risk. Objective To determine whether time-varying BP measurements are associated with a higher risk of progression of CKD than baseline BP measurements. Design, Setting, and Participants The ongoing longitudinal, prospective cohort study Chronic Kidney Disease ...
Source
#1Derek K. Ng (Johns Hopkins University)H-Index: 18
#2Matthew B. Matheson (Johns Hopkins University)H-Index: 15
Last. Alvaro Muñoz (Johns Hopkins University)H-Index: 99
view all 6 authors...
The Chronic Kidney Disease in Children Study, a prospective cohort study with data collected from 2003 to 2018, provided the first opportunity to characterize the incidence of renal replacement therapy (RRT) initiation over the life course of pediatric kidney diseases. In the current analysis, parametric generalized gamma models were fitted and extrapolated for RRT overall and by specific treatment modality (dialysis or preemptive kidney transplant). Children were stratified by type of diagnosis...
Source
Background Although pharmacotherapeutic proteinuria lowering was found to be nephroprotective in adults, the predictive value of early drug-induced proteinuria reduction for long-term renal survival in pediatric CKD is unknown. We analyzed data from the ESCAPE Trial for a potential association between initial antiproteinuric effect of standardized angiotensin-converting enzyme (ACE) inhibition and renal disease progression in children with CKD. Methods In total, 280 eligible children with CKD st...
29 CitationsSource
#1Gina Marie BarlettaH-Index: 13
#2Christopher B. Pierce (Johns Hopkins University)H-Index: 15
Last. Joseph T. Flynn (Boston Children's Hospital)H-Index: 58
view all 7 authors...
Uncontrolled hypertension in children with chronic kidney disease (CKD) has been identified as one of the main factors contributing to progression of CKD and increased risk for cardiovascular disease. Recent efforts to achieve better blood pressure (BP) control have been recommended. The primary objective of this analysis was to compare BP control over 2 time periods among participants enrolled in the CKiD study (Chronic Kidney Disease in Children). Casual BP and 24-hour ambulatory BP monitor da...
14 CitationsSource
Statistical adjustment is a ubiquitous practice in all quantitative fields that is meant to correct for improprieties or limitations in observed data, to remove the influence of nuisance variables or to turn observed correlations into causal inferences. These adjustments proceed by reporting not what was observed in the real world, but instead modeling what would have been observed in an imaginary world in which specific nuisances and improprieties are absent. These techniques are powerful and u...
7 CitationsSource
#1Joseph T. Flynn (Seattle Children's)H-Index: 58
#2David C. Kaelber (Case Western Reserve University)H-Index: 21
view all 20 authors...
These pediatric hypertension guidelines are an update to the 2004 “Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents.” Significant changes in these guidelines include (1) the replacement of the term “prehypertension” with the term “elevated blood pressure,” (2) new normative pediatric blood pressure (BP) tables based on normal-weight children, (3) a simplified screening table for identifying BPs needing further evaluation, (4) a simplifi...
824 CitationsSource
#1Alison G. Abraham (Johns Hopkins University)H-Index: 31
#2Aisha Betoko (Johns Hopkins University)H-Index: 13
Last. Alvaro Muñoz (Johns Hopkins University)H-Index: 99
view all 7 authors...
Background Clinical care decisions to treat chronic kidney disease (CKD) in a growing child must often be made without the benefit of evidence from clinical trials. We used observational data from the Chronic Kidney Disease in Children cohort to estimate the effectiveness of renin–angiotensin II–aldosterone system blockade (RAAS) to delay renal replacement therapy (RRT) in children with CKD.
9 CitationsSource
#1Empar Lurbe (ISCIII: Carlos III Health Institute)H-Index: 35
#2Enrico Agabiti-Rosei (University of Brescia)H-Index: 58
Last. Alberto Zanchetti (University of Milan)H-Index: 129
view all 19 authors...
Increasing prevalence of hypertension (HTN) in children and adolescents has become a significant public health issue driving a considerable amount of research. Aspects discussed in this document include advances in the definition of HTN in 16 year or older, clinical significance of isolated systolic HTN in youth, the importance of out of office and central blood pressure measurement, new risk factors for HTN, methods to assess vascular phenotypes, clustering of cardiovascular risk factors and tr...
381 CitationsSource
#1Bradley A. Warady (Children's Mercy Hospital)H-Index: 75
#2Alison G. Abraham (Johns Hopkins University)H-Index: 31
Last. Susan L. Furth (Children's Hospital of Philadelphia)H-Index: 68
view all 13 authors...
Background Few studies have prospectively evaluated the progression of chronic kidney disease (CKD) in children and adolescents, as well as factors associated with progression. Study Design Prospective multicenter observational cohort study. Setting & Participants 496 children and adolescents with CKD enrolled in the Chronic Kidney Disease in Children (CKiD) Study. Predictors Proteinuria, hypoalbuminemia, blood pressure, dyslipidemia, and anemia. Outcomes Parametric failure-time models were used...
110 CitationsSource
Cited By0
Newest